Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Japan Medical Materials (JMM) was a prominent Japanese medical device company specializing in the development and manufacture of orthopedic and dental implants. Established in 2004 as a joint venture between Kyocera Corporation and Kobe Steel, the company integrated Kyocera's advanced ceramic technologies with Kobe Steel's metallurgical expertise. JMM became a market leader in Japan for artificial hip and knee joints, notably through its Bioceram product line. In 2012, Kyocera acquired Kobe Steel's stake to make JMM a wholly-owned subsidiary, subsequently renaming it Kyocera Medical Corporation. The business was fully merged into Kyocera Corporation in 2017, where it continues to operate as a core part of Kyocera's medical business division.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Japan Medical Materials.